We are live on ! Find out more
CCB

Cutter & Co Brokerage Portfolio holdings

AUM $423M
1-Year Est. Return 15.02%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+15.02%
3 Year Est. Return
+40.36%
5 Year Est. Return
+171.67%
10 Year Est. Return
+252.8%
AUM
$342M
AUM Growth
+$3.12M
Cap. Flow
+$4.62M
Cap. Flow %
1.35%
Top 10 Hldgs %
47.04%
Holding
222
New
10
Increased
83
Reduced
78
Closed
13

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$1.5M
2
ET icon
Energy Transfer Partners
ET
+$1.03M
3
LIN icon
Linde
LIN
+$986K
4
NVO
Novo Nordisk
NVO
+$867K
5
OXY icon
Occidental Petroleum
OXY
+$725K

Sector Composition

Rank Sector Weight
1 Financials 16.33%
2 Healthcare 14.8%
3 Energy 13.94%
4 Industrials 13.74%
5 Materials 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.1T
$50.2M 14.68%
143,435
-245
-0.2% -$86.9K
NVO
2
Novo Nordisk
NVO
$208B
$26.5M 7.76%
291,916
+9,838
+3% +$867K
EPD icon
3
Enterprise Products Partners
EPD
$82.3B
$17.5M 5.11%
639,191
+7,405
+1% +$198K
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.36T
$14M 4.1%
106,380
-833
-0.8% -$108K
CP icon
5
Canadian Pacific Kansas City
CP
$78.1B
$12.7M 3.71%
170,769
+7,916
+5% +$628K
LIN icon
6
Linde
LIN
$221B
$12.6M 3.69%
33,936
+2,590
+8% +$986K
HEI icon
7
HEICO Corp
HEI
$49.8B
$7.71M 2.25%
47,607
+4,167
+10% +$707K
AWK icon
8
American Water Works
AWK
$26.7B
$6.64M 1.94%
53,627
+396
+0.7% +$55.5K
REGN icon
9
Regeneron Pharmaceuticals
REGN
$78.5B
$6.64M 1.94%
8,067
-54
-0.7% -$42.4K
AAPL icon
10
Apple
AAPL
$4.54T
$6.34M 1.85%
37,059
+38
+0.1% +$6.97K
ET icon
11
Energy Transfer Partners
ET
$70.1B
$5.91M 1.73%
421,372
+77,352
+22% +$1.03M
BCPC
12
Balchem Corp
BCPC
$5.38B
$5.19M 1.52%
41,853
+5,111
+14% +$679K
OXY icon
13
Occidental Petroleum
OXY
$56.8B
$4.7M 1.37%
72,392
+11,519
+19% +$725K
WSO icon
14
Watsco Inc
WSO
$12.7B
$4.65M 1.36%
12,307
-13
-0.1% -$4.7K
UNP icon
15
Union Pacific
UNP
$174B
$4.63M 1.35%
22,729
+247
+1% +$53.8K
VRTX icon
16
Vertex Pharmaceuticals
VRTX
$121B
$4.17M 1.22%
12,001
-109
-0.9% -$38.1K
CDRE icon
17
Cadre Holdings
CDRE
$1.32B
$4.05M 1.18%
152,027
-26,207
-15% -$640K
NFG icon
18
National Fuel Gas
NFG
$7.82B
$3.89M 1.14%
75,015
-1,493
-2% -$78.6K
LLY icon
19
Eli Lilly
LLY
$1.02T
$3.71M 1.08%
6,906
-7
-0.1% -$3.61K
ZBRA icon
20
Zebra Technologies
ZBRA
$14B
$3.69M 1.08%
15,591
+909
+6% +$247K
VOO icon
21
Vanguard S&P 500 ETF
VOO
$979B
$3.65M 1.07%
9,294
+271
+3% +$111K
CVX icon
22
Chevron
CVX
$392B
$3.6M 1.05%
21,350
-438
-2% -$70.7K
PEP icon
23
PepsiCo
PEP
$190B
$3.41M 1%
20,109
-21
-0.1% -$3.81K
INGR icon
24
Ingredion
INGR
$6.27B
$3.4M 0.99%
34,577
+990
+3% +$103K
MKC icon
25
McCormick & Company Non-Voting
MKC
$13.7B
$3.39M 0.99%
44,806
-45
-0.1% -$3.76K

Similar funds

Cutter & Co Brokerage's Q3 2023 Portfolio in Review

As of Q3 2023, Cutter & Co Brokerage held 222 positions worth $342M, up 0.92% from $339M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Cutter & Co Brokerage's Q3 2023 filing shows 10 new, 83 increased, 78 reduced and 13 closed positions. Its largest new stake was Invesco NASDAQ 100 ETF: 2,558 shares worth $377K. The largest sale was CVS Health, an estimated $928K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Energy.

  • Cutter & Co Brokerage's largest Q3 2023 buy was Invesco NASDAQ 100 ETF: 2,558 shares worth $377K.
  • Cutter & Co Brokerage added most to L3Harris in Q3 2023, an estimated $1.5M increase.
  • Cutter & Co Brokerage's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $892K.
  • Cutter & Co Brokerage fully exited CVS Health in Q3 2023, selling an estimated $928K.
  • Cutter & Co Brokerage's ten largest holdings make up 47% of its $342M portfolio in Q3 2023.
  • Cutter & Co Brokerage opened 10 new positions and closed 13 in Q3 2023.
  • Cutter & Co Brokerage's portfolio value rose 0.92% quarter-over-quarter to $342M.

Based on Cutter & Co Brokerage's 13F filing for Q3 2023, filed 31 Oct 2023.